封面
市場調查報告書
商品編碼
1291348

基因治療市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Gene Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2022年,全球基因治療市場規模達到44億美元。展望未來,IMARC Group預計,到2028年,市場規模將達到109億美元,在2023-2028年期間呈現15.39%的成長率(CAGR)。遺傳性疾病和獲得性疾病的發病率越來越高;醫院、診所和療養院的建設越來越多;以及新的基因療法的普及,為鴉片類藥物提供了更安全、無成癮性的替代品,這些都是推動市場的一些關鍵因素。

慢性病的發生率上升促進了市場成長

各種慢性病在群眾中的發病率越來越高,這是推動基因治療市場成長的關鍵因素之一。除此之外,由於採用不健康的生活方式,各種慢性病的發生,如心血管併發症、糖尿病、甲狀腺炎和肥胖症,也促進了市場的成長。此外,大眾中癌症病例的增加,以及對有效的腫瘤治療需求的成長,正在提供一個有利的市場前景。此外,由於過度吸煙的習慣,慢性肺部疾病的發生率越來越高,這也促進了基因治療市場的成長。

報告中涵蓋了競爭分析,如市場結構、主要參與者的市場佔有率、參與者定位、頂尖的製勝戰略、競爭儀表板和公司評估象限。此外,還提供了所有主要公司的詳細簡介。由於存在大量的全球和區域參與者,基因治療市場的結構是適度分散的。由於需要高額的資本投資、嚴格的政府政策,市場上新進入者的數量是適中的,而且產品差異化率很低。

什麼是基因治療?

基因治療是一種通過修改變異基因的表達或改變活細胞的生物特性來預防疾病進展的技術,用於治療。它包括不同的產品,如病毒載體、細菌載體、質粒脫氧核糖核酸(DNA)、人類基因編輯技術和病人衍生的細胞基因治療。它涉及將一個健康的基因引入個人的基因組,以修復促使遺傳疾病的突變。它包括各種療法,如體外、體內和原位基因療法。基因治療的功能是通過基因抑制、基因增強,並最終殺死致病細胞。它可以治愈某些藥物無法預防的疾病,並有可能永久地擺脫疾病症狀。它還能提高身體對抗各種疾病的能力,如癌症、糖尿病、血友病、囊性纖維化、心臟病和獲得性免疫缺陷症候群(AIDS)。此外,由於基因療法不像其他藥物那樣需要多次用藥,其需求在世界各地不斷增加。

COVID-19的影響:

冠狀病毒的爆發嚴重擾亂了基因治療市場,影響了各生物製藥公司的業績。一些基因治療公司由於其複雜的製造和交付系統以及籌資模式,面臨著大量的複雜問題。治療的製造和交付、研究和臨床開發以及商業運作受到大流行病的負面影響,這促使了基因治療市場成長的中斷。此外,支持基因治療產品的製造和開發的供應鏈需要受控和複雜的環境。供應鏈受到了封鎖和對通過道路移動的限制的嚴重影響。此外,有幾家公司報告說,由於COVID-19的爆發,經營出現了延誤或完全停止。

基因治療市場趨勢:

目前,對基因治療的需求不斷成長,因為它能有效地治愈各種危急和威脅生命的疾病,是積極影響市場的主要因素之一。除此之外,遺傳性疾病和後天性疾病在大眾中的流行率上升,也推動了市場的成長。此外,世界各地越來越多的醫院、診所和療養院的建設,為病人提供高品質的醫療保健服務,也促進了市場的成長。除此之外,新的基因療法的普及,為治療廣泛的慢性疼痛疾病,如下背痛和罕見的神經性疼痛疾病,提供了一個更安全和無成癮性的替代品,並創造有利的市場前景。

目錄

第一章:前言

第二章:範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章:執行摘要

第四章:簡介

  • 概述
  • 主要行業趨勢

第五章:全球基因治療市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章:按基因類型分類的市場

  • 抗原
    • 市場趨勢
    • 市場預測
  • 細胞因子
    • 市場趨勢
    • 市場預測
  • 腫瘤抑制因子
    • 市場趨勢
    • 市場預測
  • 自殺基因
    • 市場趨勢
    • 市場預測
  • 缺陷
    • 市場趨勢
    • 市場預測
  • 成長因素
    • 市場趨勢
    • 市場預測
  • 受體
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第7章:按載體類型分類的市場

  • 病毒載體
    • 市場趨勢
    • 關鍵部分
      • 腺病毒
      • 慢病毒
      • 逆轉錄病毒
      • 腺相關病毒
      • 單純皰疹病毒
      • 痘病毒
      • 疫苗病毒
      • 其他病毒
    • 市場預測
  • 非病毒性技術
    • 市場趨勢
    • 關鍵領域
      • 裸體和質粒載體
      • 基因槍
      • 電穿孔
      • 脂質感染
      • 其他領域
    • 市場預測

第8章:按給藥方式分類的市場

  • 體內基因治療
    • 市場趨勢
    • 市場預測
  • 體外基因治療
    • 市場趨勢
    • 市場預測

第九章:按應用分類的市場

  • 腫瘤性疾病
    • 市場趨勢
    • 市場預測
  • 罕見病
    • 市場趨勢
    • 市場預測
  • 心血管疾病
    • 市場趨勢
    • 市場預測
  • 神經系統疾病
    • 市場趨勢
    • 市場預測
  • 傳染性疾病
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第十章:按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十一章:SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十二章:價值鏈分析

第十三章:波特五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十四章:價格分析

第十五章:競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的概況
    • Abeona Therapeutics Inc.
    • Adaptimmune Therapeutics plc
    • Adverum Biotechnologies Inc.
    • Amgen Inc.
    • Astellas Pharma Inc.
    • Biogen Inc.
    • Bluebird Bio Inc.
    • Mustang Bio Inc. (Fortress Biotech Inc.)
    • Novartis AG
    • Orchard Therapeutics plc
    • UniQure NV
    • Voyager Therapeutics Inc.
Product Code: SR112023A5026

The global gene therapy market size reached US$ 4.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2028, exhibiting a growth rate (CAGR) of 15.39% during 2023-2028. The growing prevalence of inherited diseases and acquired disorders; increasing construction of hospitals, clinics, and nursing homes; and rising popularity of new gene therapy that offers a safer, non-addictive alternative to opioids represent some of the key factors driving the market.

Rising Occurrence of Chronic Diseases Augmenting Market Growth

The increasing prevalence of various chronic diseases among the masses represents one of the key factors propelling the growth of the gene therapy market. Besides this, the occurrence of various chronic diseases, such as cardiovascular complications, diabetes, thyroiditis, and obesity, due to the adoption of unhealthy lifestyle patterns is contributing to the growth of the market. Moreover, rising cases of cancer among the masses, along with the growing demand for effective oncology treatment, is offering a favorable market outlook. Furthermore, the increasing occurrence of chronic lung diseases due to excessive smoking habits is bolstering the growth of the gene therapy market.

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The structure of the gene therapy market is moderately fragmented due to the presence of a large number of global and regional players. The volume of new entrants in the market is moderate due to the requirement for high capital investments, stringent government policies, and the rate of product differentiation is low.

What is Gene Therapy?

Gene therapy is a technique for preventing disease progression by modifying the expression of mutated genes or altering the biological properties of living cells for therapeutic use. It comprises different products, such as viral vectors, bacterial vectors, plasmid deoxyribonucleic acid (DNA), human gene-editing technology, and patient-derived cellular gene therapy. It involves the introduction of a healthy gene into the genome of an individual to repair a mutation that is causing a genetic disorder. It consists of various therapies, such as ex vivo, in vivo, and in situ gene therapy. Gene therapy functions via gene inhibition, gene augmentation, and ultimately killing the disease-causing cells. It can cure certain diseases which no medications can prevent and has the potential to get rid of disease symptoms permanently. It also improves the ability of the body to fight against a wide variety of diseases, such as cancer, diabetes, hemophilia, cystic fibrosis, heart disease, and acquired immunodeficiency syndrome (AIDS). Furthermore, as gene therapy does not require multiple doses like other medications, its demand is increasing around the world.

COVID-19 Impact:

The outbreak of coronavirus severely disrupted the gene therapy market and affected the performance of various biopharmaceutical companies. Some gene therapy companies faced an immense number of complications due to their complicated manufacturing and delivery systems and funding models. The manufacture and delivery of treatment, research and clinical development, and commercial operations were negatively impacted by the pandemic, which resulted in a disruption in the growth of the gene therapy market. In addition, the supply chains that support the manufacturing and development of gene therapy products require controlled and complex settings. The supply chain was severely impacted by lockdowns and restrictions imposed on movement via roads. Furthermore, several companies reported delays or complete halts in operations due to the outbreak of COVID-19.

Gene Therapy Market Trends:

At present, the growing demand for gene therapy, as it is effective in curing various critical and life-threatening diseases, represents one of the primary factors influencing the market positively. Besides this, the rising prevalence of inherited diseases and acquired disorders among the masses is propelling the growth of the market. In addition, the increasing construction of hospitals, clinics, and nursing homes around the world to provide quality healthcare services to patients is contributing to the growth of the market. Apart from this, the rising popularity of new gene therapy that offers a safer and non-addictive alternative to opioids in treating a broad range of chronic pain conditions, such as lower back pain and rare neuropathic pain disorders, is offering a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global gene therapy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on gene type, vector type, delivery method and application.

Gene Type Insights:

Antigen

Cytokine

Tumor Suppressor

Suicide Gene

Deficiency

Growth Factors

Receptors

Others

The report has provided a detailed breakup and analysis of the gene therapy market based on the gene type. This includes antigen, cytokine, tumor suppressor, suicide gene, deficiency, growth factors, receptors, and others.

Vector Type Insights:

Viral Vector

Adenoviruses

Lentiviruses

Retroviruses

Adeno-Associated Virus

Herpes Simplex Virus

Poxvirus

Vaccinia Virus

Others

Non-Viral Techniques

Naked and Plasmid Vectors

Gene Gun

Electroporation

Lipofection

Others

A detailed breakup and analysis of the gene therapy market based on the vector type has also been provided in the report. This includes viral vector (adenoviruses, lentiviruses, retroviruses, adeno-associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others) and non-viral techniques (naked and plasmid vectors, gene gun, electroporation, lipofection, and others). According to the report, viral vector (adenoviruses, lentiviruses, retroviruses, adeno-associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others) accounted for the largest market share as it is highly efficient in mitigating the impacts of infectious diseases and viruses. In addition, the rising utilization of viral vectors as they are easy to handle and modify is propelling the growth of the respective segment.

Delivery Method Insights:

In-Vivo Gene Therapy

Ex-Vivo Gene Therapy

A detailed breakup and analysis of the gene therapy market based on the delivery method has also been provided in the report. This includes in-vivo gene therapy and ex-vivo gene therapy.

Application Insights:

Oncological Disorders

Rare Diseases

Cardiovascular Diseases

Neurological Disorders

Infectious Disease

Others

A detailed breakup and analysis of the gene therapy market based on the application has also been provided in the report. This includes oncological disorders, rare diseases, cardiovascular diseases, neurological disorders, infectious disease, and others. According to the report, oncological disorders accounted for the largest market share due to increasing occurrence of cancer among the masses. Apart from this, the rising employment of gene therapy in cancer treatment as it provides remarkable efficacy is bolstering the growth of the market.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for gene therapy. Some of the factors driving the North America gene therapy market included the rising awareness about the benefits of gene therapy in treating various chronic diseases and the increasing expenditure in research and development (R&D) activities to develop effective gene therapies is propelling the market growth. In addition, the growing construction of various healthcare facilities to provide quality treatment to patients is propelling the growth of the market.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global gene therapy market. Some of the companies covered in the report include:

Abeona Therapeutics Inc.

Adaptimmune Therapeutics plc

Adverum Biotechnologies Inc.

Amgen Inc.

Astellas Pharma Inc.

Biogen Inc.

Bluebird Bio Inc.

Mustang Bio Inc. (Fortress Biotech Inc.)

Novartis AG

Orchard Therapeutics plc

UniQure N.V.

Voyager Therapeutics Inc.

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

1. What was the size of the global gene therapy market in 2022?

2. What is the expected growth rate of the global gene therapy market during 2023-2028?

3. What are the key factors driving the global gene therapy market?

4. What has been the impact of COVID-19 on the global gene therapy market?

5. What is the breakup of the global gene therapy market based on the vector type?

6. What is the breakup of the global gene therapy market based on the application?

7. What are the key regions in the global gene therapy market?

8. Who are the key players/companies in the global gene therapy market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Gene Therapy Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Gene Type

  • 6.1  Antigen
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Cytokine
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Tumor Suppressor
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Suicide Gene
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5  Deficiency
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6  Growth Factors
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7  Receptors
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8  Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7   Market Breakup by Vector Type

  • 7.1  Viral Vector
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Adenoviruses
      • 7.1.2.2 Lentiviruses
      • 7.1.2.3 Retroviruses
      • 7.1.2.4 Adeno-Associated Virus
      • 7.1.2.5 Herpes Simplex Virus
      • 7.1.2.6 Poxvirus
      • 7.1.2.7 Vaccinia Virus
      • 7.1.2.8 Others
    • 7.1.3 Market Forecast
  • 7.2  Non-Viral Techniques
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Naked and Plasmid Vectors
      • 7.2.2.2 Gene Gun
      • 7.2.2.3 Electroporation
      • 7.2.2.4 Lipofection
      • 7.2.2.5 Others
    • 7.2.3 Market Forecast

8   Market Breakup by Delivery Method

  • 8.1  In-Vivo Gene Therapy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Ex-Vivo Gene Therapy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9   Market Breakup by Application

  • 9.1  Oncological Disorders
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Rare Diseases
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3  Cardiovascular Diseases
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4  Neurological Disorders
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5  Infectious Disease
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6  Others
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  Abeona Therapeutics Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2  Adaptimmune Therapeutics plc
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3  Adverum Biotechnologies Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4  Amgen Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5  Astellas Pharma Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6  Biogen Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7  Bluebird Bio Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8  Mustang Bio Inc. (Fortress Biotech Inc.)
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9  Novartis AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10  Orchard Therapeutics plc
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11  UniQure N.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12  Voyager Therapeutics Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials

List of Figures

  • Figure 1: Global: Gene Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Gene Therapy Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Gene Therapy Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Gene Therapy Market: Breakup by Gene Type (in %), 2022
  • Figure 5: Global: Gene Therapy Market: Breakup by Vector Type (in %), 2022
  • Figure 6: Global: Gene Therapy Market: Breakup by Delivery Method (in %), 2022
  • Figure 7: Global: Gene Therapy Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Gene Therapy Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Gene Therapy (Antigen) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Gene Therapy (Antigen) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Gene Therapy (Cytokine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Gene Therapy (Cytokine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Gene Therapy (Tumor Suppressor) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Gene Therapy (Tumor Suppressor) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Gene Therapy (Suicide Gene) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Gene Therapy (Suicide Gene) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Gene Therapy (Deficiency) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Gene Therapy (Deficiency) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Gene Therapy (Growth Factors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Gene Therapy (Growth Factors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Gene Therapy (Receptors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Gene Therapy (Receptors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Gene Therapy (Other Gene Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Gene Therapy (Other Gene Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Gene Therapy (Viral Vector) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Gene Therapy (Viral Vector) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Gene Therapy (Non-Viral Techniques) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Gene Therapy (Non-Viral Techniques) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Gene Therapy (In-Vivo Gene Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Gene Therapy (In-Vivo Gene Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Gene Therapy (Ex-Vivo Gene Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Gene Therapy (Ex-Vivo Gene Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Gene Therapy (Oncological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Gene Therapy (Oncological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Gene Therapy (Rare Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Gene Therapy (Rare Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Gene Therapy (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Gene Therapy (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Gene Therapy (Neurological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Gene Therapy (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Gene Therapy (Infectious Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Gene Therapy (Infectious Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Gene Therapy (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Gene Therapy (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: North America: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: North America: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: United States: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: United States: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Canada: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Canada: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Asia-Pacific: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Asia-Pacific: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: China: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: China: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Japan: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Japan: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: India: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: India: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: South Korea: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: South Korea: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Australia: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Australia: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Indonesia: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Indonesia: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Others: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Others: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Europe: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Europe: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Germany: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Germany: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: France: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: France: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: United Kingdom: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: United Kingdom: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Italy: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Italy: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Spain: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Spain: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Russia: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Russia: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Latin America: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Latin America: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Brazil: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Brazil: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Mexico: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Mexico: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Others: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Others: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Middle East and Africa: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Middle East and Africa: Gene Therapy Market: Breakup by Country (in %), 2022
  • Figure 93: Middle East and Africa: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 94: Global: Gene Therapy Industry: SWOT Analysis
  • Figure 95: Global: Gene Therapy Industry: Value Chain Analysis
  • Figure 96: Global: Gene Therapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Gene Therapy Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Gene Therapy Market Forecast: Breakup by Gene Type (in Million US$), 2023-2028
  • Table 3: Global: Gene Therapy Market Forecast: Breakup by Vector Type (in Million US$), 2023-2028
  • Table 4: Global: Gene Therapy Market Forecast: Breakup by Delivery Method (in Million US$), 2023-2028
  • Table 5: Global: Gene Therapy Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Gene Therapy Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Gene Therapy Market: Competitive Structure
  • Table 8: Global: Gene Therapy Market: Key Players